Phase I safety investigation of an aerosolized, recombinant alpha 1-antitrypsin in subjects with alpha 1-antitrypsin deficiency
R. Sandhaus, J. Stocks, J. Stoller, D. Gelmont, D. Sundin, M. Brantly (Denver, Tyler, Cleveland, Westlake Village, Alameda, Gainesville, United States Of America)
Source: Annual Congress 2004 - Emphysema and oxygen therapy
Session: Emphysema and oxygen therapy
Session type: Oral Presentation
Number: 1509
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Sandhaus, J. Stocks, J. Stoller, D. Gelmont, D. Sundin, M. Brantly (Denver, Tyler, Cleveland, Westlake Village, Alameda, Gainesville, United States Of America). Phase I safety investigation of an aerosolized, recombinant alpha 1-antitrypsin in subjects with alpha 1-antitrypsin deficiency. Eur Respir J 2004; 24: Suppl. 48, 1509
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: